To further investigate the factors secreted by CAFs that enhance PTX resistance in BC cells, we reviewed the literature and found that CAFs promote anti-androgen resistance in prostate cancer and trastuzumab resistance in BC through the secretion of NRG1 [15, 17]. Here, NRG1 is linked to prostate carcinoma.